Physician Scientist and Pediatric Cardiologist | Formerly @BCH_HeartCenter @HMSGenetics @HarvardMed @TheBCRP @lab_olson @UTSWmstp

Boston, MA
Dan Quiat retweeted
Inherited cardiomyopathies are entering a new era. First-in-human gene therapy trials are now underway for MYBPC3, PKP2, BAG3, LAMP2B, and FXN and more. My review on where the field stands, in Circ: Heart Failure ahajrnls.org/48RvWjy
2
3
6
455
Dan Quiat retweeted
Pediatric massive left ventricular hypertrophy (mLVH) is a risk factor for sudden cardiac death (SCD) and other adverse events in children with hypertrophic cardiomyopathy (HCM). ahajrnls.org/496Y6XA
6
11
4,532
Dan Quiat retweeted
Thrilled to share our research on a novel method to visualize and isolate border zone cardiomyocytes! Powerful new tool to study their contribution to heart repair and regeneration. @URMC_DeptMed #URochesterResearch
Sprr1a acts a novel marker for specific subpopulation of border zone cardiomyocytes in mice, that survive myocardial infarction, facilitating their direct visualization, isolation, and longitudinal tracking. ahajrnls.org/3OmYZUW
1
4
7
1,665
Dan Quiat retweeted
In this commentary we discuss WHO needs genetic testing, WHY we need it, and HOW we can test. Genetic testing provides valuable information for our patients with HF and their families. @fatkinlab #JACCHF #Genetics #HeartFailure
Genetic CMPs are an under-recognized cause of #HF. Pathogenic variants: ~20% in #DCM, ~30% in HCM, & up to 45% in advanced HF, yet <2% of eligible patients undergo testing. A call to advance precision medicine in HF care? jacc.org/doi/10.1016/j.jchf.… #JACCHF #cvHCM #HeartFailure
1
2
22
2,293
Dan Quiat retweeted
Very excited to share our commentary where we discuss WHO needs genetic testing, WHY we need it, and HOW we can test (sciencedirect.com/science/ar…). Genetic testing provides valuable information for our patients with HF and their families. @fatkinlab @JACCJournals #JACCHF #Genetics
2
20
1,355
Dan Quiat retweeted
Excited to share our latest publication where we identified a novel and essential role of TTN enhancer. Thanks to @MerajNeyazi @KGkatzis @zoltarany @ArunSharmaPhD @ChrisToepfer @GOuditResearch @williampu66 @AxelVisel @BrighamWomens @harvardmed @bwhcvls and all others #Genetics
Titin, the largest known human protein, is vital for normal heart muscle contraction. @yurikim_mdphd, @MerajNeyazi & team @harvardmed now discover an intron-mediated enhancer that regulates TTN gene expression and cardiomyocyte contractility: jci.org/articles/view/183353
6
7
60
3,691
Thrilled to see this collaborative effort published! Many thanks to my brilliant collaborators and mentors
Titin, the largest known human protein, is vital for normal heart muscle contraction. @yurikim_mdphd, @MerajNeyazi & team @harvardmed now discover an intron-mediated enhancer that regulates TTN gene expression and cardiomyocyte contractility: jci.org/articles/view/183353
4
14
903
Dan Quiat retweeted
Dr. @MerajNeyazi educating us on single cell transcriptomic signatures of cardiac sarcoidosis and fantastic questions by the audience! @GOuditResearch @MartinBeyer_ @UKEHamburg @harvardmed @AHAScience @American_Heart #AHA2024 #sarcoidosis
4
21
2,640
Dan Quiat retweeted
Very excited to share our AHA Science Advisory where we discuss current promises and limitations of gene therapy in CVD. It was such an honor to work with @APLandstrom @SvatiShah @Joseph_C_Wu, Kricket, @AHAScience @American_Heart and @CircAHA @bwhcvls @BrighamWomens #GeneTherapy
CVD is the leading cause of 🌏 morbidity & mortality. Many are caused by damaging DNA 🧬 variants and require lifelong treatments that mitigate but do not cure disease. This advisory looks at gene therapies to treat CVD. ✍🏼: @yurikim_mdphd @APLandstrom @SvatiShah @Joseph_C_Wu
5
9
65
4,593
Dan Quiat retweeted
Just in time for #ChildhoodCancerAwarenessMonth, the Voit lab is hiring! We looking for interested and interesting post-doc candidates to join our team @UTSWMedCenter focused at the intersection of hematopoiesis, cancer biology, and gene therapy. tinyurl.com/Voit-lab-postdoc
2
11
18
3,427
Dan Quiat retweeted
The #SEQUOIA #HCM trial results are here - Placebo-controlled trial of #aficamten in #obstructive #HCM 3 presentations in 3 threads - follow along This is the first presentation by @MartinMaronMD sharing the primary results Follow along #CardioTwitter #HeartFailure2024
3
35
80
44,128
Dan Quiat retweeted
Acto3D: an open-source user-friendly volume rendering software for high-resolution 3D fluorescence imaging in biology Read this Techniques and Resources Article by Naoki Takeshita, Kenta Yashiro @drkyashiro_kpum and colleagues: journals.biologists.com/dev/…
2
21
85
13,731
A major adverse effect of statins is myopathy (known since 1980). Now genetics have shed light on this association. Two independent teams have recently discovered that recessive mutations in HMGCR cause a severe form of muscular disease in humans. A 🧵 for genetics lovers.
8
125
420
153,719
We at the CureHeart team are looking for an enthusiastic colleague to help us test and design genetic cures for inherited heart muscle diseases. We are working with human iPSCs and cutting edge CRISPR/Cas9 technologies to design these treatments. tinyurl.com/CureHeart1
1
15
39
8,527
In Opinion “Today, I will explain to my healthy transplanted heart why, in what may be a matter of days or weeks at best, she — well, we — will die,” writes Amy Silverstein, an author, in a guest essay. nyti.ms/3V0iodr
41
129
807
1,098,868
Dan Quiat retweeted
Excited to report our collaborative efforts to better understand mechanisms behind beneficial effects of ARB in early-stage HCM! ahajournals.org/doi/abs/10.1… Thanks to @ulvedreng @sday_hcm @HenningBundgaa1 @tikuowens @CarolynHoMD @bwhcvls @BrighamResearch and many others
9
8
56
6,632
Cardiomyocyte infection by Trypanosoma cruzi promotes innate immune response and glycolysis activation. Study by great friends @harvardmed Spearheaded by Gabriela Venturini! frontiersin.org/articles/10.…
3
15
1,644
6 Weeks Left to Apply for the #AVCIA Catalyst Award! #postdocs #ECR #FundingOpportunity #singleventricle 💲 Award supports up to $1.2M over 6 years 🗓️ LOI due March 16th Learn more and download the RFP here: additionalventures.org/initi…
1
208